XML 37 R26.htm IDEA: XBRL DOCUMENT
v3.24.3

Accrued Expenses (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Accrued Expenses [Abstract] |
Accrued Expenses | Accrued expenses consisted of the following:
|  | September 30, |  |  | December 31, |
|  | 2024 |  |  | 2023 |
Accrued interest |  | $ | 352,775 |  |  |  | — |
Clinical trial costs |  |  | 350,208 |  |  |  | 276,141 |
Incentive and other compensation costs |  |  | 297,897 |  |  |  | 1,082,606 |
Director fees |  |  | 70,000 |  |  |  | 60,210 |
Franchise taxes |  |  | 3,150 |  |  |  | 12,160 |
Other |  |  | 53,615 |  |  |  | 13,179 |
Accrued expenses |  | $ | 1,127,645 |  |  |  | 1,444,296 |

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration